Celyad Oncology SA Cash Conversion Cycle 2011-2026 | CYAD

Annual Cash Conversion Cycle Celyad Oncology SA

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-55.7 K	-3 M	-	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
-55.7 K	-3 M	-1.53 M

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	173	$ 3.56	2.01 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Aptorum Group Limited APM	-400	$ 0.79	-0.79 %	$ 4.31 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Arcturus Therapeutics Holdings ARCT	21.2	$ 6.63	-0.75 %	$ 182 M	Israel
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Anika Therapeutics ANIK	270	$ 14.36	1.13 %	$ 210 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
AVEO Pharmaceuticals AVEO	-123	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.64	3.94 %	$ 16.6 M	USA
BioCardia BCDA	101	$ 1.27	0.79 %	$ 26.9 M	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain